SOAT1 and acute lymphoblastic leukemia: The use of the JAK2 inhibitor TG101209 suppressed T-ALL proliferation by regulating both the JAK-STAT pathway and the crosstalk between apoptosis and autophagy and ultimately inhibiting T-ALL cell proliferation.